39 Results

People

  1. Janjigian
    Janjigian
  2. Ilson
    Ilson
  3. Kelsen
    Kelsen
  4. Ku
    Ku
  5. Strong
    Strong
  6. Tang
    Tang
  7. Coit
    Coit
  8. Bains
    Bains
  9. Capanu
    Capanu
  10. Chou
    Chou

Groups

  1. Department of Medicine (39)
  2. Gastrointestinal Oncology Service (39)
  3. Solid Tumor Oncology Division (39)
  4. Center for Pancreatic Cancer Research (22)
  5. Epidemiology and Biostatistics (22)
  6. Biostatistics Service (21)
  7. Survivorship Research (19)
  8. Surgery (18)
  9. Hematologic Malignancies, Division of (14)
  10. Sloan Kettering Institute Postdocs (14)
  1. "adult"
  2. "Yelena Janjigian"
Formats
  1. Journal Article (36)
  2. Review (2)
  3. Conference Paper (1)
Groups
  1. Department of Medicine (39)
  2. Gastrointestinal Oncology Service (39)
  3. Solid Tumor Oncology Division (39)
  4. Center for Pancreatic Cancer Research (22)
  5. Epidemiology and Biostatistics (22)
  6. Biostatistics Service (21)

More Groups

People
  1. Yelena Janjigian (39)
  2. David Ilson (13)
  3. David Kelsen (12)
  4. Laura Tang (12)
  5. Geoffrey Ku (11)
  6. Marinela Capanu (10)

More People

Years
  1. 2024 (1)
  2. 2023 (8)
  3. 2022 (5)
  4. 2021 (1)
  5. 2020 (4)
  6. 2018 (3)

More Years

Publications
  1. Annals of Surgery (5)
  2. Lancet Oncology (4)
  3. Annals of Surgical Oncology (3)
  4. Clinical Cancer Research (3)
  5. Future Oncology (2)
  6. Journal of Gastrointestinal Oncology (2)

More Publications

Publishers
  1. Elsevier Science, Inc. (6)
  2. American Association for Cancer Research (5)
  3. Lippincott Williams & Wilkins (5)
  4. Springer (5)
  5. Oxford University Press (4)
  6. Future Medicine (2)

More Publishers

Results (39)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): An interim analysis of the multicentre, double-blind, randomised phase 3 study
    Journal Article

    Shitara, K.; Rha, S. Y.; Wyrwicz, L. S.; Oshima, T.; Karaseva, N.; Osipov, M.; Yasui, H.; Yabusaki, H.; Afanasyev, S.; Park, Y. K.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: A single-arm, single-centre, phase 2 trial
    Journal Article

    Cytryn, S. L.; Moy, R. H.; Cowzer, D.; Shah, R. H.; Chou, J. F.; Joshi, S. S.; Ku, G. Y.; Maron, S. B.; Desai, A.; Yang, J.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • Perioperative versus total neoadjuvant chemotherapy in gastric cancer
    Journal Article

    Yang, J.; Greally, M.; Strong, V. E.; Coit, D. G.; Chou, J. F.; Capanu, M.; Maron, S. B.; Kelsen, D. P.; Ilson, D. H.; Janjigian, Y. Y.; more...
    Journal of Gastrointestinal Oncology (2023)

    Fulltext@MSK | Save
  • Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): Primary and updated analyses from a single-arm, phase 2 study
    Journal Article

    Van Cutsem, E.; di Bartolomeo, M.; Smyth, E.; Chau, I.; Park, H.; Siena, S.; Lonardi, S.; Wainberg, Z. A.; Ajani, J.; Chao, J.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • A plain language summary of the CheckMate 649 study: Nivolumab in combination with chemotherapy compared to chemotherapy alone for untreated advanced or metastatic cancer of the stomach or esophagus
    Review

    Janjigian, Y. Y.; Shitara, K.; Moehler, M.; Garrido, M.; Salman, P.; Wyrwicz, L.; Yamaguchi, K.; Skoczylas, T.; Bragagnoli, A. C.; Liu, T.; more...
    Future Oncology (2023)

    Fulltext@MSK | Save
  • Waiting to operate: The risk of salvage esophagectomy
    Journal Article

    Boerner, T.; Harrington, C.; Tan, K. S.; Adusumilli, P. S.; Bains, M. S.; Bott, M. J.; Downey, R. J.; Huang, J.; Ilson, D. H.; Isbell, J. M.; more...
    Annals of Surgery (2023)

    Fulltext@MSK | Save
  • Distinct differences in gastroesophageal junction and gastric adenocarcinoma in 2194 patients: In memory of Rebecca A. Carr, February 24, 1988-January 19, 2021
    Journal Article

    Nakauchi, M.; Vos, E. L.; Carr, R. A.; Barbetta, A.; Tang, L. H.; Gonen, M.; Russo, A.; Janjigian, Y. Y.; Yoon, S. S.; Sihag, S.; more...
    Annals of Surgery (2023)

    Fulltext@MSK | Save
  • Clinical importance of clonal hematopoiesis in metastatic gastrointestinal tract cancers
    Journal Article

    Diplas, B. H.; Ptashkin, R.; Chou, J. F.; Sabwa, S.; Foote, M. B.; Rousseau, B.; ArgileĢs, G.; White, J. R.; Stewart, C. M.; Bolton, K.; more...
    JAMA Network Open (2023)

    Fulltext@MSK | Save
  • Induction FOLFOX and PET-directed chemoradiation for locally advanced esophageal adenocarcinoma
    Journal Article

    Carr, R. A.; Hsu, M.; Harrington, C. A.; Tan, K. S.; Bains, M. S.; Bott, M. J.; Ilson, D. H.; Isbell, J. M.; Janjigian, Y. Y.; Maron, S. B.; more...
    Annals of Surgery (2023)

    Fulltext@MSK | Save
  • A novel microbiome signature in gastric cancer: A two independent cohort retrospective analysis
    Conference Paper

    Abate, M.; Vos, E.; Gonen, M.; Janjigian, Y. Y.; Schattner, M.; Laszkowska, M.; Tang, L.; Maron, S. B.; Coit, D. G.; Vardhana, S.; more...
    Lippincott Williams & Wilkins (2022)

    Fulltext@MSK | Save